A phase 3, open-label period followed by a randomized, double-blind, placebo-controlled study of the analgesic efficacy and safety of extended release hydrocodone/acetaminophen [paracetamol] (Vicodin CR) compared to placebo in subjects with chronic low back pack

Trial Profile

A phase 3, open-label period followed by a randomized, double-blind, placebo-controlled study of the analgesic efficacy and safety of extended release hydrocodone/acetaminophen [paracetamol] (Vicodin CR) compared to placebo in subjects with chronic low back pack

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Jul 2011

At a glance

  • Drugs Hydrocodone/paracetamol (Primary)
  • Indications Back pain
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Abbott Laboratories
  • Most Recent Events

    • 08 May 2008 Results were presented in a media release. The primary endpoint was met.
    • 24 Oct 2007 Status changed from in progress to completed.
    • 14 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top